| GO:0000166 |
F |
nucleotide binding |
| GO:0004016 |
F |
adenylate cyclase activity |
| GO:0004383 |
F |
guanylate cyclase activity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0005524 |
F |
ATP binding |
| GO:0005525 |
F |
GTP binding |
| GO:0005886 |
C |
plasma membrane |
| GO:0006182 |
P |
cGMP biosynthetic process |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007166 |
P |
cell surface receptor signaling pathway |
| GO:0007168 |
P |
receptor guanylyl cyclase signaling pathway |
| GO:0008074 |
C |
guanylate cyclase complex, soluble |
| GO:0008217 |
P |
regulation of blood pressure |
| GO:0009190 |
P |
cyclic nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016829 |
F |
lyase activity |
| GO:0016849 |
F |
phosphorus-oxygen lyase activity |
| GO:0016941 |
F |
natriuretic peptide receptor activity |
| GO:0017046 |
F |
peptide hormone binding |
| GO:0019901 |
F |
protein kinase binding |
| GO:0030828 |
P |
obsolete positive regulation of cGMP biosynthetic process |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0042417 |
P |
dopamine metabolic process |
| GO:0042562 |
F |
hormone binding |
| GO:0043235 |
C |
receptor complex |
| GO:0048662 |
P |
negative regulation of smooth muscle cell proliferation |
| GO:0050880 |
P |
blood vessel diameter maintenance |
